Jan 2, 2015
Dear Nelson,I appreciate you so much for your many great helps in defending HIV disease and consulting service. According to Ibalizumab ,on 2014,sep 22 you told us as below: No news yet. Still waiting.... .Do you have more update status about Ibalizumab . I do hope the drug can be approved by FDA soon and patient can get one more useful drug to defend HIV. May you have a happy New Year.
Response from Mr. Vergel
I have good news.
Ibalizumab IV has been given an orphan drug designation on Oct 20, 2014 by the FDA, which makes it possible for Taimed to get more funding for the required studies for its eventual approval for patients with few HIV medication options due to multidrug resistance. This is the first time in history that an HIV medication has been granted orphan drug designation.
Another piece of good news is that doctors can apply to provide this drug as part of a single patient TIND via this process:
Most patients who need ibalizumab may also need another medication to combine it with. Fortunately, BMS is soon launching their study for their attachment inhibitor which will allow the use of ibalizumab.
I will post an update once the BMS study is started and I have an update meeting with Taimed to find out more about their study to lead to approval.
Undetectable top and negative bottom on PrEP - risk of transmission
Gastric bypass alternative (correction)
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.